HSD17B2 and breast carcinoma: One example is a point mutation in putative TATA box of 17 beta-hydroxysteroid dehydrogenase 2 (EDH17B2) gene, which has been suggested as a candidate for the familial breast cancer gene together with the breast cancer type 1 susceptibility protein (BRCA1) gene.